Israel Englander’s Madrigal Pharmaceuticals MDGL Stock Holding History

Israel Englander’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$698K	Buy	+1,300	New	+$666K	﹤0.01%	4556
2025 Q1	–	Sell	-1,700	Closed	-$525K	–	6192
2024 Q4	$525K	Sell	1,700 -8,300	-83%	-$2.33M	﹤0.01%	4713
2024 Q3	$2.12M	Buy	10,000 +2,500	+33%	+$640K	﹤0.01%	3652
2024 Q2	$2.1M	Buy	+7,500	New	+$1.79M	﹤0.01%	3501
2024 Q1	–	Sell	-10,400	Closed	-$2.41M	–	6460
2023 Q4	$2.41M	Sell	10,400 -2,900	-22%	-$507K	﹤0.01%	3455
2023 Q3	$1.94M	Buy	+13,300	New	+$2.5M	﹤0.01%	3580
2023 Q1	–	Sell	-24,800	Closed	-$7.2M	–	6653
2022 Q4	$7.2M	Buy	24,800 +21,400	+629%	+$2.09M	﹤0.01%	2478
2022 Q3	$221K	Buy	+3,400	New	+$236K	﹤0.01%	5591

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's MDGL Position: Q2 2026 in Review

Israel Englander increased its Madrigal Pharmaceuticals (MDGL) stake by 99% in Q2 2026, buying an estimated $20.7M and bringing the position to 81,196 shares worth $43.6M. The position accounts for 0.02% of the portfolio, ranked #983.

Israel Englander first reported a position in MDGL in Q2 2013 and has held it in 40 quarters since. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Israel Englander held 81,196 shares of Madrigal Pharmaceuticals worth $43.6M as of Q2 2026.
Israel Englander bought 40,343 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $20.7M.
Madrigal Pharmaceuticals made up 0.02% of Israel Englander's portfolio in Q2 2026, its #983 holding.
Israel Englander first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.